Sensei Biotherapeutics Inc expected to post a loss of $5.60 a share - Earnings Preview

Faeth Therapeutics,

01/08/2025 14:48

Sensei Biotherapeutics Inc SNSE.OQ SNSE.O is expected to  show no change in quarterly revenue when it reports  results on August 4 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Sensei Biotherapeutics Inc is for a loss of $5.60 per share.

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Sensei Biotherapeutics Inc is $67.50, about 88.9% above its last closing price of $7.48

This summary was machine generated August 1 at 13:48 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)